Another stream of revenue added. I would definitely be buying the product when it becomes available. Step by step, GC is building Todos in to a formidable player in the hottest market at the moment. The company is way undervalued due to lack of visibility. Not sure how soon, but that is going to change.
(2)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links